Sminu Bose, MD
Gynecologic Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Uterine Sarcoma
- Uterine Leiomyosarcoma
- Endometrial Stromal Sarcoma
Request an Appointment
About Me
- Assistant Attending Physician
I am a gynecologic oncologist dedicated to the care of women with gynecologic cancers, including:
I am an expert in using systemic treatments (drugs that spread throughout the body to treat disease), such as immunotherapy, targeted therapy, and chemotherapy to treat gynecologic cancers. Although I treat all gynecologic cancers, I have a particular focus on rare types, like uterine sarcoma. This includes leiomyosarcoma, high-grade undifferentiated sarcomas, endometrial stromal sarcomas, and perivascular epithelioid cell neoplasms, among others.
Read more
Treating gynecologic cancers often requires a multidisciplinary approach (experts from many teams, like surgery and radiation oncology). I work with an expert team of gynecologic surgeons, radiation oncologists, pathologists, and radiologists to develop personalized treatment plans for everyone in my care. It is important that my patients leave my office feeling comfortable and confident in their care plan. To create an environment where this is possible, I encourage questions and open, honest discussion.
I am also very active in clinical research with the Gynecologic Medical Oncology Service. Much of my work focuses on the development of novel treatments for women with uterine sarcomas. I have been involved in several multi-institutional and national research studies and recently won two Merit Awards from Conquer Cancer®, the ASCO Foundation for my contributions in this area.
I earned my medical degree from The Johns Hopkins School of Medicine and completed my residency and oncology fellowship training at NewYork-Presbyterian Hospital/Columbia University Medical Center. My dedication to a career in oncology is long-standing, and my personal experience of having a loved one with cancer drives me to provide the best care that I can for my patients.
A gynecologic (GY-neh-kuh-LAH-jik) oncologist is a cancer doctor with special training in the gynecologic system. This includes cervical, fallopian tube, ovarian, uterine, vaginal, and vulvar cancers.
My Specialties
- Uterine Sarcoma
- Uterine Leiomyosarcoma
- Endometrial Stromal Sarcoma
- Perivascular Epithelioid Cell Neoplasms
Education
- MD, Johns Hopkins University School of Medicine
Residencies
- Internal Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center
Awards and Honors
- QuadW Foundation Endowed Merit Award, Conquer Cancer Foundation/American Society of Clinical Oncology (2023)
- Jed Ian Taxel Foundation for Rare Cancer Research (2022)
- Sherwin Family Endowed Merit Award, Conquer Cancer Foundation/American Society of Clinical Oncology (2022)
- Methods in Clinical Cancer Research Workshop, American Association of Cancer Research/American Society of Clinical Oncology (2022)
- Dr. Joseph N. Muschel Housestaff Award, Columbia University Medical Center (2020)
- Meltzer Ethics Award, Columbia University Medical Center (2019)
- Cancer in the Underprivileged, Indigent, Disadvantaged (CUPID) Translational Oncology Research Fellowship, Johns Hopkins University School of Medicine (2014)
- Presidential Scholarship, Johns Hopkins University School of Medicine, (2013-2017)
- Woodrow Wilson Research Fellowship, Johns Hopkins University (2009-2012)
- James R. Hoffa Merit Scholarship, International Brotherhood of Teamsters (2009-2012)
- George Washington University Medal for Engineering and Applied Science, George Washington University (2008)
- Cancer Research Training Award, National Cancer Institute (2008)
Fellowships
- Hematology and Medical Oncology, NewYork-Presbyterian Hospital/Columbia University Medical Center
Board Certifications
- Internal Medicine
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, HMO
MSK has a tentative agreement with Cigna to continue coverage in 2024.
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Bose sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Bose
- A Phase 2/3 Study of Olaparib and Temozolomide Versus the Usual Treatment of Trabectedin or Pazopanib for Metastatic Uterine Leiomyosarcoma
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Ingham M, Allred JB, Chen L, Das B, Kochupurakkal B, Gano K, George S, Attia S, Burgess MA, Seetharam M, Boikos SA, Bui N, Chen JL, Close JL, Cote GM, Thaker PH, Ivy SP, Bose S, D’Andrea A, Marino-Enriquez A, Shapiro GI, Schwartz GK. Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). J Clin Oncol. 2023 Sep 1;41(25):4154-4163. doi: 10.1200/JCO.23.00402. Epub 2023 Jul 19. PMID: 37467452.
Lacuna K, Bose S, Ingham M, Schwartz G. Therapeutic advances in leiomyosarcoma. Front Oncol. 2023 Mar 8;13:1149106. doi: 10.3389/fonc.2023.1149106. PMID: 36969049; PMCID: PMC10031121.
Bose S, Schwartz GK, Ingham M. Novel Therapeutics in the Treatment of Uterine Sarcoma. Am Soc Clin Oncol Educ Book. 2022 Apr;42:900-909. doi: 10.1200/EDBK_350541. PMID: 35714303.
Read more
Bose S, Lee T, Choi S, Fazlollahi L, Rasiej MJ, Schwartz GK, Ingham M. CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone. JCO Precis Oncol. 2022 Jul;6:e2100550. doi: 10.1200/PO.21.00550. PMID: 35820086.
Visit PubMed for a full listing of Dr. Bose’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.